Endoscopy 2011; 43(7): 591-595
DOI: 10.1055/s-0030-1256489
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Analysis of variables associated with surgery versus observation in patients with pancreatic cystic lesions referred for endoscopic ultrasound

A.  V.  Sahai1 , T.  S.  Chua1 , S.  Paquin1 , G.  Gariepy1
  • 1Department of Gastroenterology, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
Further Information

Publication History

submitted 24 June 2010

accepted after revision 2 March 2011

Publication Date:
24 May 2011 (online)

Introduction

Pancreatic cystic lesions are usually pseudocysts or cystic neoplasms. Cystic neoplasms of the pancreas constitute about 10 % of all pancreatic cystic lesions and may be classified as malignant, premalignant, or benign [1]. Cystic lesions with malignant potential include mucinous cystic neoplasms, intraductal papillary mucinous neoplasms, papillary cystic neoplasms, and cystic islet cell tumors. Serous cyst adenomas are usually benign [2].

In surgical candidates, EUS with EUS-guided cyst puncture is often requested for cyst fluid analysis (CFA). The hope is that morphological features seen at EUS combined with the results of CFA (for cytology, pancreatic enzymes, and cyst fluid tumor markers) will help decide which patients require surgery, as opposed to conservative management (i. e. “operate versus observe”).

There are numerous studies suggesting that EUS and CFA may (or may not) reliably distinguish benign from malignant or premalignant cysts [4] [5] [6] [7] [8]. However, no studies have assessed whether and to what extent EUS findings alone or in conjunction with EUS CFA findings actually affect the decision to operate (or to observe). We hypothesized that, despite the fact that EUS with CFA may appear to be a clinically useful tool in this clinical context, it is infrequently a strong determinant of whether operation or observation is chosen as the clinical management strategy. Other variables such as patient age, presence of symptoms, and cyst size, etc., may be stronger determinants of surgery versus observation. If this is the case, one may wonder if the inherent risks (e. g. hemorrhage, cyst infection) and costs of EUS with CFA are truly justified for this indication.

This study was not designed to determine the accuracy of EUS and CFA for diagnosing pancreatic cysts; rather, it was designed to study whether EUS and CFA results actually affect the decision to operate on such lesions. The specific aim of this study was to determine the variables associated with surgery (versus observation) in patients with pancreatic cysts in whom EUS-FNA for CFA was requested.

References

  • 1 Fernandez-Del Castillo C, Warshaw A L. Cystic tumors of the pancreas.  Surg Clin North Am. 1995;  75 1001-1016
  • 2 Compton C C. Histology of cystic tumors of the pancreas.  Gastrointest Endosc Clin N Am. 2002;  12 673-696
  • 3 Warshaw A L, Compton C C, Lewandrowski K et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients.  Ann Surg. 1990;  212 432-435
  • 4 Sedlack R, Affi A, Vanquez-Sequeiros E et al. Utility of EUS in the evaluation of cystic pancreatic lesions.  Gastrointest Endosc. 2002;  56 543-547
  • 5 Michael H, Gress F. Diagnosis of cystic neoplasms with endoscopic ultrasound.  Gastrointest Endoscopy Clin N Am. 2002;  12 719-733
  • 6 Frossard J L, Amouyal P, Amouyal G et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions.  Am J Gastroenterol.. 2003;  98 1516-1524
  • 7 Mishra G, Fosmark C. Cystic neoplasms of the pancreas.  Curr Treat Opt Gastroenterol. 2000;  3 355-362
  • 8 Brandwein S L, Farrell J J, Centeno B A, Brugge W R. Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS.  Gastrointest Endosc. 2001;  53 722-727
  • 9 Hammel P, Levy P, Voitot H et al. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas.  Gastroenterology. 1995;  108 1230-1235
  • 10 George D H, Murphy F, Michalski R, Ulmer B G. Serous cystadenocarcinoma of the pancreas: a new entity?.  Am J Surg Pathol.. 1989;  13 61-66
  • 11 Maker A V, Lee L S, Raut C P et al. Cytology from pancreatic cysts has marginal utility in surgical decision-making.  Ann Surg Oncol.. 2008;  15 3187-3192
  • 12 Khalid A, Brugge W. Practice guidelines for the diagnosis and management of neoplastic pancreatic cysts.  Am J Gastroenterol. 2007;  102 2339-2349

A. V. SahaiMD 

Department of Gastroenterology
CHUM – Hôpital Saint Luc

1058 Rue Saint Denis
Montreal
Québec
Canada, H2X 3J4

Fax: +1-514-412-7372

Email: anand.sahai@sympatico.ca

    >